Literature DB >> 9795212

MU-opioid receptor-knockout mice: role of mu-opioid receptor in morphine mediated immune functions.

S Roy1, R A Barke, H H Loh.   

Abstract

The role of the mu-opioid receptor in immune function was investigated using mu-opioid receptor knockout mice (MOR-KO). Morphine modulation of several immune functions, including macrophage phagocytosis and macrophage secretion of TNF-alpha, was not observed in the MOR-KO animals, suggesting that these functions are mediated by the classical mu-opioid receptor. In contrast, morphine reduction of splenic and thymic cell number and mitogen-induced proliferation were unaffected in MOR-KO mice, as was morphine inhibition of IL-1 and IL-6 secretion by macrophages. These latter results are consistent with morphine action on a naloxone insensitive morphine receptor, a conclusion supported by previous studies characterizing a nonopioid morphine binding site on immune cells. Alternatively, morphine may act either directly or indirectly on these cells, by a mechanism mediated by either delta or kappa opioid receptors. Copyright 1998 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9795212     DOI: 10.1016/s0169-328x(98)00212-5

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  33 in total

Review 1.  Microbial infections, immunomodulation, and drugs of abuse.

Authors:  Herman Friedman; Catherine Newton; Thomas W Klein
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

2.  Study on the activation of the opioid receptors by a set of morphine derivatives in a well-defined assay system.

Authors:  Yan Zhang; Zhiwei Wang; D Phillip Cox; Olivier Civelli
Journal:  Neurochem Res       Date:  2011-10-16       Impact factor: 3.996

3.  Consequences of opioid receptor mutation on actions of univalent and bivalent kappa and delta ligands.

Authors:  Michael A Ansonoff; Philip S Portoghese; John E Pintar
Journal:  Psychopharmacology (Berl)       Date:  2010-03-24       Impact factor: 4.530

Review 4.  Modulation of immune function by morphine: implications for susceptibility to infection.

Authors:  Sabita Roy; Jinghua Wang; Jennifer Kelschenbach; Lisa Koodie; Josephine Martin
Journal:  J Neuroimmune Pharmacol       Date:  2006-03       Impact factor: 4.147

5.  Mu opioid receptor expression is increased in inflammatory bowel diseases: implications for homeostatic intestinal inflammation.

Authors:  D Philippe; D Chakass; X Thuru; P Zerbib; A Tsicopoulos; K Geboes; P Bulois; M Breisse; H Vorng; J Gay; J-F Colombel; P Desreumaux; M Chamaillard
Journal:  Gut       Date:  2005-11-18       Impact factor: 23.059

Review 6.  The gut-brain interaction in opioid tolerance.

Authors:  Hamid I Akbarali; William L Dewey
Journal:  Curr Opin Pharmacol       Date:  2017-11-13       Impact factor: 5.547

7.  μ-Opioid receptor gene A118G polymorphism predicts survival in patients with breast cancer.

Authors:  Andrey V Bortsov; Robert C Millikan; Inna Belfer; Richard L Boortz-Marx; Harendra Arora; Samuel A McLean
Journal:  Anesthesiology       Date:  2012-04       Impact factor: 7.892

8.  Morphine decreases bacterial phagocytosis by inhibiting actin polymerization through cAMP-, Rac-1-, and p38 MAPK-dependent mechanisms.

Authors:  Jana Ninković; Sabita Roy
Journal:  Am J Pathol       Date:  2012-01-14       Impact factor: 4.307

9.  Prenatal opiate exposure attenuates LPS-induced fever in adult rats: role of interleukin-1beta.

Authors:  Kathryn L Hamilton; La 'Tonyia M Franklin; Sabita Roy; Lisa M Schrott
Journal:  Brain Res       Date:  2006-12-28       Impact factor: 3.252

10.  Inducible expression of functional mu opioid receptors in murine dendritic cells.

Authors:  Zheng-Hong Li; Niansheng Chu; Li-Dong Shan; Shan Gong; Qi-Zhang Yin; Xing-Hong Jiang
Journal:  J Neuroimmune Pharmacol       Date:  2009-02-03       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.